Form 4 for EQH Equitable Holdings, Inc.
Accepted 2024-03-04 00:00:00 ET · period of report 2024-03-01 · accession 0000950170-24-024962 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2024-03-04 | 2024-03-01 | EQH | Pearson Mark | Pres, CEO, Dir | S - Sale+OE | $33.77 | -60.0K | 723.3K | -8% | -$2.03M |
| DT | 2024-03-04 | 2024-03-01 | EQH | Pearson Mark | Pres, CEO, Dir | M - OptEx | $21.34 | +40.0K | 763.3K | +6% | +$853.6K |
| DT | 2024-03-04 | 2024-03-01 | EQH | Pearson Mark | Pres, CEO, Dir | M - OptEx | $0.00 | -40.0K | 606.4K | -6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-01 | S | D | 20,000 | $33.77 | 703,254.38 | D | — | — | (F1) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 13, 2023. (F4) This transaction was executed in multiple trades at prices ranging from $33.5100 to $34.2400. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Includes Restricted Stock Units. |
| 2 | Common | Common Stock | 2024-03-01 | S | D | 40,000 | $33.77 | 723,254.38 | D | — | — | (F1) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 13, 2023. (F3) This transaction was executed in multiple trades at prices ranging from $33.4700 to $34.2400. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Includes Restricted Stock Units. |
| 3 | Common | Common Stock | 2024-03-01 | M | A | 40,000 | $21.34 | 763,254.38 | D | — | — | (F1) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 13, 2023. (F2) Includes Restricted Stock Units. |
| 4 | Derivative | Employee Stock Option (right to buy) | 2024-03-01 | M | D | 40,000 | $0.00 | 606,400 | D | $21.34 · — to 2028-03-01 | 40,000 Common Stock | (F1) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 13, 2023. (F5) Grant of employee stock option under the Issuer's 2019 Omnibus Incentive Plan exempt under Rule 16b-3. The options vest/vested in three installments beginning on March 1, 2019. |